论文部分内容阅读
本文报道一种被称为CB 0006的α肿瘤坏死因子(TNF-α)单抗对严重脓毒性休克的初步临床试验结果。 CB 0006是鼠抗人重组TNF-α的单克隆抗体,可中和TNF-α的细胞毒性,阻断TNF-α
This article reports the results of a preliminary clinical trial of a TNF-α monoclonal antibody called CB 0006 on severe septic shock. CB 0006 is a monoclonal antibody to murine anti-human recombinant TNF-α that neutralizes cytotoxicity of TNF-α and blocks TNF-α